|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Weill Medical College of Cornell University Agency for Healthcare Research and Quality (AHRQ) |
|---|---|
| Information provided by: | Weill Medical College of Cornell University |
| ClinicalTrials.gov Identifier: | NCT00773500 |
Purpose
Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a before and after prospective study of multiple small private physician practices and community health centers.
| Condition | Intervention |
|---|---|
|
Medication Error |
Other: Electronic prescribing |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Official Title: | Impact of Vendor Systems on Ambulatory Medication Safety |
| Estimated Enrollment: | 100 |
| Study Start Date: | September 2008 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
Providers not adopting electronic prescribing in New York City, New York
|
|
|
2
Providers adopting electronic prescribing in New York City, New York
|
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
|
|
3
Providers not adopting electronic prescribing in the Taconic region of New York
|
|
|
4
Providers adopting electronic prescribing in the Taconic region of New York
|
Other: Electronic prescribing
Implementation of a commercially available electronic prescribing system with clinical decision support
|
We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time, comparing medication safety among recent adopters (who adopted electronic prescribing < 6 months ago) to experienced users (who have been using electronic prescribing for ≥ 1 year).
Study design will be a before and after prospective study of multiple small private physician practices and community health centers.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Our study will take place in 2 communities located in New York. We will select 2 communities in order to assemble a study population with the following characteristics: use of at least 2 different vendor-based systems across the communities, use of at least 2 HIE systems across the communities, different implementation times (with some communities being early adopters and others experienced users), and inclusion of urban underserved and federally defined rural areas.
We will select the following 2 communities/organizations: the community health centers implementing electronic prescribing with the New York City Department of Health (NYC DOH) and the Taconic Health Information Network and Community (THINC) in the Hudson Valley of New York. Both communities have expressed their interest in participating in this study.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, New York | |
| New York City Department of Health and Mental Hygiene | |
| New York, New York, United States, 10038 | |
| Taconic IPA | |
| Fishkill, New York, United States, 12524 | |
More Information
| Responsible Party: | Weill Cornell Medical College ( Rainu Kaushal, MD, MPH ) |
| Study ID Numbers: | U18HS0169705E |
| Study First Received: | October 3, 2008 |
| Last Updated: | October 15, 2008 |
| ClinicalTrials.gov Identifier: | NCT00773500 |
| Health Authority: | United States: Institutional Review Board |
